BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6367010)

  • 1. Native and degraded fibronectin: new immunological methods for distinction.
    Selmer J; Eriksen H; Clemmensen I
    Scand J Clin Lab Invest; 1984 Feb; 44(1):57-63. PubMed ID: 6367010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies on amniotic fluid and plasma fibronectins.
    Ruoslahti E; Engvall E; Hayman EG; Spiro RG
    Biochem J; 1981 Jan; 193(1):295-9. PubMed ID: 7305927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A weaker gelatin-binding affinity and increased glycosylation of amniotic fluid fibronectin than plasma fibronectin.
    Yamaguchi Y; Isemura M; Yosizawa Z; Kan M; Sato A
    Int J Biochem; 1986; 18(5):437-43. PubMed ID: 3709931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of fibronectin metabolites in normal rat urine.
    Nagai T; Fujita H; Suzuki H; Fukai F; Katayama T
    Biochim Biophys Acta; 1988 Nov; 967(2):176-82. PubMed ID: 3191150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive enzyme immunoassay for quantification of the cellular form of fibronectin (EDAcFN) in blood samples.
    Ylätupa S; Partanen P; Haglund C; Virtanen I
    J Immunol Methods; 1993 Jul; 163(1):41-7. PubMed ID: 8335958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of Human Plasma/Cellular Fibronectin and Fibronectin Fragments.
    Pietrocola G; Rindi S; Nobile G; Speziale P
    Methods Mol Biol; 2017; 1627():309-324. PubMed ID: 28836210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concentration of the cellular fibronectin in amniotic fluid and plasma in the peripartum period].
    Hirnle L; Gospodarek A; Katnik-Prastowska I
    Ginekol Pol; 2001 Dec; 72(12):1149-53. PubMed ID: 11883227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin from human germ-cell tumors resembles amniotic fluid fibronectin.
    Ruoslahti E; Jalanko H; Comings DE; Neville AM; Raghavan D
    Int J Cancer; 1981 Jun; 27(6):763-7. PubMed ID: 7026463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amniotic fluid fibronectin concentrations with advancing gestational age.
    Harris MC; Mennuti MT; Kline JA; Polin RA
    Obstet Gynecol; 1988 Oct; 72(4):593-5. PubMed ID: 3419738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ED-A sequence containing fibronectin in human amniotic fluid and amnion epithelial cells.
    Vartio T; Von Koskull H; Virtanen I
    Int J Biochem; 1989; 21(3):307-11. PubMed ID: 2663562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin-binding peptides. I. Isolation and characterization of two unique fibronectin-binding peptides from gelatin.
    Gao X; Groves MJ
    Eur J Pharm Biopharm; 1998 May; 45(3):275-84. PubMed ID: 9653632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin quantification without antibodies: a bioassay for the detection of the gelatin-captured macromolecule.
    Pataki A; Madarász E; Kurucz I
    J Biochem Biophys Methods; 2006 Aug; 68(2):113-26. PubMed ID: 16780955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy.
    Cederholm B; Wieslander J; Bygren P; Heinegård D
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4865-8. PubMed ID: 3387443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Highly purified, functionally active human fibronectin preparation].
    Regnault V; Rivat C; Maugras M; Stoltz JF
    Rev Fr Transfus Immunohematol; 1988 Feb; 31(1):19-34. PubMed ID: 3399792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions.
    Vuento M; Vaheri A
    Biochem J; 1979 Nov; 183(2):331-7. PubMed ID: 534500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different molecular forms of fibronectin in rheumatoid synovial fluid.
    Clemmensen I; Andersen RB
    Arthritis Rheum; 1982 Jan; 25(1):25-31. PubMed ID: 7066034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin and immune complexes in rheumatic diseases.
    Herbert KE; Coppock JS; Griffiths AM; Williams A; Robinson MW; Scott DL
    Ann Rheum Dis; 1987 Oct; 46(10):734-40. PubMed ID: 3500676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causal relationship between conformational change and inhibition of domain functions of glycoxidative fibronectin.
    Sakata N; Sasatomi Y; Ando S; Meng J; Imanaga Y; Uesugi N; Takebayashi S
    Connect Tissue Res; 2000; 41(2):117-29. PubMed ID: 10992158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the carbohydrate moieties of plasma and amniotic fluid fibronectins as revealed by crossed immunoaffinity electrophoresis with concanavalin A.
    Yamaguchi Y; Isemura M; Yosizawa Z; Sato A; Suzuki M
    Tohoku J Exp Med; 1983 Nov; 141(3):359-67. PubMed ID: 6648974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantification of fibronectin in the plasma, cerebrospinal fluid and amniotic fluid by enzymo-immunoanalysis].
    León VJ; León E; Moraleda JM; López-Borrasca A
    Sangre (Barc); 1986; 31(2):161-6. PubMed ID: 3523797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.